• Fund Type: Open-End Fund
  • Objective: Growth Broad Market
  • Asset Class: Equity
  • Geographic Focus: China

Chang Xin Domestic Demand Growth Fund

+ Add to Watchlist

CXDMDMG:CH

1.01 CNY 0.01 0.79%

As of 12:03:31 ET on 04/16/2014.

Snapshot for Chang Xin Domestic Demand Growth Fund (CXDMDMG)

Year To Date: +13.98% 3-Month: +8.57% 3-Year: - 52-Week Range: 0.98 - 1.40
1-Month: -1.15% 1-Year: +51.63% 5-Year: - Beta vs : -

Mutual Fund Chart for CXDMDMG

No chart data available.
  • CXDMDMG:CH 1.01
  • 1M
  • 1Y
Interactive CXDMDMG Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for CXDMDMG

Chang Xin Domestic Demand Growth Fund is an open-end fund incorporated in China. The Fund's objective is long-term capital stability and growth. The Fund invests 60-95% in equities of companies that benefit from fast-growing domestic demand in China.

Inception Date: 10-21-2011 Telephone: 86-21-5058 8999
Managers: AN YUN
Web Site: www.cxfund.com.cn

Fundamentals for CXDMDMG

NAV (on 2014-04-16) 1.01
Assets (M) (on 2013-12-31) 47.49
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment 1,000.00

Dividends for CXDMDMG

Dividend Type Distribution
Dividend Frequency Irreg
Last Dividend Net (on 2014-03-25) 0.30
Dividend Yield (ttm) 44.55

Fees & Expenses for CXDMDMG

Front Load -
Back Load 0.50
Current Mgmt Fee 1.50
Redemption Fee 0.50
12b1 Fee -
Expense Ratio -

Top Fund Holdings for CXDMDMG

Filing Date: 12/31/2013
Name Position Value % of Total
Zhejiang Dian Diagnostics Co L 69,608 4,083,901 8.740%
Aier Eye Hospital Group Co Ltd 130,041 4,058,580 8.680%
Shanghai Kingstar Winning Soft 49,381 3,585,554 7.670%
By-health Co Ltd 44,036 3,209,784 6.870%
Guizhou Yibai Pharmaceutical C 96,000 3,131,520 6.700%
Hangzhou Tigermed Consulting C 44,717 2,844,001 6.080%
Heilan Home Co Ltd 396,000 2,803,680 6.000%
Tasly Pharmaceutical Group Co 62,663 2,687,616 5.750%
Shanghai Kaibao Pharmaceutical 176,000 2,569,600 5.500%
Jiangsu Nhwa Pharmaceutical Co 89,997 2,535,215 5.420%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil